Brief: PYC Therapeutics Announces Residency At Johnson & Johnson Innovation, JLabs
15/06/2021 12:41
June 15 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* PYC THERAPEUTICS ESTABLISHING NEW U.S. HEADQUARTERS IN SAN
DIEGO, ANNOUNCES RESIDENCY AT JOHNSON & JOHNSON INNOVATION,
JLABS
* PYC THERAPEUTICS LTD - COMPANY'S DRUG DISCOVERY AND
LABORATORY
OPERATIONS WILL REMAIN IN PERTH, AUSTRALIA.
Source text for Eikon: ID:nPn3QHqmJa
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director